These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23598928)

  • 1. Itraconazole as 'bridge therapy' to anti-IgE in a patient with severe asthma with fungal sensitisation.
    Pizzimenti S; Bussolino C; Badiu I; Rolla G
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23598928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe asthma with fungal sensitization.
    Agarwal R
    Curr Allergy Asthma Rep; 2011 Oct; 11(5):403-13. PubMed ID: 21789577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgE therapy for allergic bronchopulmonary aspergillosis.
    Homma T; Kurokawa M; Matsukura S; Yamaguchi M; Adachi M
    J Microbiol Immunol Infect; 2016 Jun; 49(3):459-63. PubMed ID: 24291616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum.
    Farrant J; Brice H; Fowler S; Niven R
    J Asthma; 2016 Sep; 53(7):732-5. PubMed ID: 27043956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis.
    Pasqualotto AC; Powell G; Niven R; Denning DW
    Respirology; 2009 Nov; 14(8):1121-7. PubMed ID: 19909460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
    Wolf BL; Johnson A
    J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
    Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of omalizumab in severe asthma with fungal sensitisation: a case report.
    Di Stefano F; Cinti B; Antonicelli L
    Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):56-9. PubMed ID: 24702879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of recombinant Aspergillus fumigatus antigens in diagnosing Aspergillus sensitisation among asthmatics.
    Muthu V; Singh P; Choudhary H; Dhooria S; Sehgal IS; Prasad KT; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
    Mycoses; 2020 Sep; 63(9):928-936. PubMed ID: 32490571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
    Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
    BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
    Altman MC; Lenington J; Bronson S; Ayars AG
    J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
    Jat KR; Walia DK; Khairwa A
    Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.
    Lin RY; Sethi S; Bhargave GA
    J Asthma; 2010 Oct; 47(8):942-5. PubMed ID: 20831464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients.
    Tanimoto H; Fukutomi Y; Yasueda H; Takeuchi Y; Saito A; Watai K; Sekiya K; Tsuburai T; Asano K; Taniguchi M; Akiyama K
    Clin Exp Allergy; 2015 Dec; 45(12):1790-800. PubMed ID: 26118958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of effective readministration of itraconazole for recurrent allergic bronchopulmonary aspergillosis].
    Uji M; Sugama Y; Nishida K; Matsushita H
    Nihon Kokyuki Gakkai Zasshi; 2005 Jul; 43(7):412-6. PubMed ID: 16050467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
    Evans MO; Morris MJ; Coop CA; Evans SE
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
    Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
    J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.